Last month, Dr. Patti Peeples, CEO of HealthEconomics.Com, interviewed Allen Lising on how Xcenda’s FormularyDecisions™ is used early in drug development for contactless payer engagement to facilitate market access. This blog continues the conversation with Laurie Fazio, Head of FormularyDecisions’ Market Access & Growth Strategies, and explores how a small biotechnology company used the platform to make crucial decisions early in drug development, while simultaneously creating important payer relationships as they prepared for launch.
FormularyDecisions™ is a secure, online platform that facilitates the bi-directional exchange of information between life sciences companies and over 2,400 qualified, active payers in a decision-making role. The virtual platform is used from pre-approval through post-launch, providing subscribers with exclusive insights into what payers think of their product. Manufacturers can maximize brand visibility and utilize feedback to better inform market access strategies. Access the full interview with Fazio here.